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AbStr ACt
Lymphatic filariasis is an infection transmitted by blood-sucking 
mosquitoes with filarial nematodes of the species Wuchereria 
bancrofti, Brugia malayi und B. timori. It is prevalent in tropical 
countries throughout the world, with more than 60 million 
people infected and more than 1 billion living in areas with the 
risk of transmission. Worm larvae with a length of less than 
1 mm are transmitted by mosquitoes, develop in human lym-
phatic tissue to adult worms with a length of 7–10 cm, live in 
the human body for up to 10 years and produce millions of 
microfilariae, which can be transmitted further by mosquitoes. 
The adult worms can be easily observed by ultrasonography 
because of their size and fast movements (the so-called “filar-
ial dance sign”), which can be differentiated from other move-
ments (e. g., blood in venous vessels) by their characteristic 
movement profile in pulsed-wave Doppler mode. Therapeutic 
options include (combinations of) ivermectin, albendazole, 
diethylcarbamazine and doxycycline. The latter depletes en-
dosymbiotic Wolbachia bacteria from the worms and thus 
sterilizes and later kills the adult worms (macrofilaricidal or 
adulticidal effect).
Introduction
Parasitic diseases are rarely encountered in Europe and the clinical 
and imaging features are generally not well known. In the era of 
worldwide migration and refugees, knowledge of such diseases has 
gained importance as illustrated by multiple recently published re-
ports of hydatid diseases [1–5], schistosomiasis [6, 7], fasciolosis 
[8], ascariasis [9], liver flukes [10], toxocariasis and other rare in-
testinal diseases [11, 12]. This article describes the clinical and im-
aging features along with current treatment strategies for filariasis.
Across the world, nematodes (roundworms) cause a wide vari-
ety of parasitic infections of the subcutaneous and lymphatic tis-
sue of almost all organs with significant economic and psychoso-
cial damage. Three species, Wuchereria bancrofti (90 % of lymphat-
ic filariasis infections, humans are the only hosts), Brugia malayi (up 
to 10 % of lymphatic filariasis infections, humans, domestic and wild 
animals are hosts), and B. timori, cause lymphatic filariasis (LF) af-
fecting approx. 60 million patients worldwide [13]. Lymphangitis, 
lymphedema and the formation of fibrosis, sclerosis and scars are 
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by the extent and duration of the exposure to infective mosquito 
bites, the quantity of accumulating adult worm antigen in the lym-
phatics, the host immune response, and the number of secondary 
bacterial and fungal infections.
Acute disease
Acute disease is caused by spontaneous or drug-induced death of 
adult filariae, with filarial fever, chills, acute lymphadenopathy (with 
retrograde lymphangitis, mainly the inguinal lymph nodes), myal-
gia and tropical pulmonary eosinophilia with microfilariae trapped 
in the lungs characterized by nocturnal wheezing [26]. In general, 
the recurrent acute inflammation occurs once, twice or five times 
a year and resolves after few days to one week depending on sever-
ity [27–29].
Chronic disease
Local symptoms (pitting lymphedema, hydrocele) are the promi-
nent signs of chronic infection within the skin and the surrounding 
tissues, especially the lower extremities [30]. The mechanism 
might be partially explained by bacterial superinfection (e. g., in-
terdigital microtrauma), and once the lymphatic vessels are dam-
aged, lymphedema may progress even in the absence of filarial in-
fection [31]. In Brugian filariasis ulcerating abscess formation may 
occur along the involved lymphatics including the genitalia. Many 
organs can be involved, including the scrotum (scrotal lymphangi-
ectasia, hydrocele up to 30 cm, epididymitis and rarely orchitis), 
a
b
▶Fig. 1 Leg filariasis, B-mode imaging of leg filariasis a, color Dop-
pler imaging of leg filariasis b in a patient with subcutaneous thick-
ening.
the pathophysiologically important sequelae. Loiasis and oncho-
cerciasis are rarely associated with lymphedema.
LFI caused by W. bancrofti is common in the tropical regions of 
India and Southeast Asia, Pacific islands, Latin America and Carib-
bean area as well as in sub-Saharan Africa. B. malayi occurs mainly 
in China, India, Malaysia, Indonesia, the Philippines and the Pacific 
islands. B. timori occurs only on the Timor Island of Indonesia and 
some neighboring islands.
Nematodes are transmitted by mosquitoes. The mosquito vec-
tors for filariasis vary geographically including the genus Culex, 
Anopheles, Aedes, Mansonia, and Coquillettidia. Humans are the 
so-called definitive host where the sexual stages develop. The adult 
worms do not replicate in humans. Therefore travelers have a short 
exposure to infective larvae and the disease ceases generally after 
a certain period. Transmission most often happens in childhood 
[14, 15]. The disease is almost not detected in travelers and very 
rarely in expatriates.
The larvae develop into mature adult worms, which mate and 
produce sheathed microfilariae with mainly nocturnal periodicity. 
In addition, a mosquito ingests the microfilariae again during a 
blood meal; these develop into larvae, which can infect another 
human when the mosquito takes a subsequent blood meal, com-
pleting the life cycle.
The prevalence increases with age. Travelers usually have insuf-
ficient exposure to filariasis to develop sufficiently high worm bur-
dens. More often a local hypersensitivity including eosinophilic in-
filtrate with lymphangitis and lymphadenopathy, urticaria, and pe-
ripheral eosinophilia is observed.
Humans are infected during a blood meal. The mosquito-trans-
mitted larvae develop into mature adult worms in about 9 months. 
The adult parasites can be observed in lymphatic vessels. Larvae 
appear in the blood stream after a prepatent period of about 12 
months. They often show periodic activity in the blood stream. In 
areas with mosquitos that are active at night, the larvae appear in 
the blood in astonishingly precise nocturnal periods. In areas with 
mosquitos that are active during the day, the larvae can be detect-
ed in the blood during the day, e. g., Brugia malayi. The adult worms 
survive for approximately five years. The size of the filariae is spe-
cies-dependent from 10 –100 mm in length and 0.07 × 0.1 mm in 
width. In ultrasound images the echoes appear bigger than the real 
worm. Measurements resulted in echoes of up to 2.5 mm.
Filarial disease is influenced by the extent and duration of expo-
sure to infective mosquito bites, i. e., the quantity of accumulating 
adult worm antigen in the lymphatics. The adult worms in the lym-
phatics induce an inflammatory response [16] but also mechanical 
damage [17]. As rickettsia-like organisms, Wolbachia are endosym-
biotic to adult worms [18] and may be responsible for the inflam-
matory changes [19–24]. Treatment with antibiotics such as dox-
ycycline or rifampicin kills Wolbachia and as a result the adult 
worms become sterile and can no longer reproduce. As such, treat-
ed patients are no longer infectious.
Symptoms and Clinical Manifestations
Only one third of infected patients develop overt symptoms [25]. 
Symptoms range from asymptomatic to severely disabling. The se-
verity of symptoms and the course of the disease are determined 
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urogenital and renal manifestations [32–34] with chyluria (intesti-
nal lymph may be intermittently discharged into the renal pelvis 
[35], ovary and inner genital [36], eyes and heart. The hydrocele is 
a fluid collection between the parietal and visceral layers of the tu-
nica vaginalis, surrounding the testis and spermatic cord. Progres-
sive non-pitting lymphedema with limb swelling is related to chron-
ic inflammation of the lymphatic vessels resulting in hyperpigmen-
tation and hyperkeratosis and sometimes elephantiasis of the lower 
limbs. The breast can be involved in females.
Diagnosis
Confirming serological diagnosis
Blood eosinophilia is typical, sometimes exceeding 3/nL [26] and 
serves as screening in patients with typical symptoms. Diagnosis 
of LF can be best achieved by detecting circulating filarial antigen 
(CFA) of W. bancrofti-DNA in the blood [37–43], detecting circulat-
ing microfilariae or by detecting adult worms in the lymphatics 




▶Fig. 2 60-year-old patient from Guatemala, Latin America with recurrent scrotal swelling with thickness of the pure scrotum without testis of 
> 40 mm a and b, the swelling is indicated between markers) on both sides b. A hydrocele was operated on a few years ago. Treatment with meben-
dazole has been reported during that time. The “filarial dance sign” could be seen on real-time ultrasound below the testis. The testes showed in-
creased stiffness using elastography c and little contrast enhancement on contrast-enhanced ultrasound d, indicating chronic orchitis. MRI images 
(T2, koronar) are also shown e, f.
a b c
▶Fig. 3 Ultrasound of enlarged lymph vessels in the scrotal area; in the left part of the biggest vessel, a moving worm can be detected a. On pulse 
wave Doppler, the movements appear as irregular amplitudes b and can be differentiated from pulsating vessels c.
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alternative in settings where antigen testing is not available. Blood 
tests have better sensitivity than biopsy and histological evalua-
tion [45, 46]. CFA is diagnostic in W. bancrofti only but false-posi-
tive W. bancrofti antigen testing may occur in patients with severe 
circulating Loa loa microfilariae [47, 48]. Negative blood results 
have been observed in treated “burned out” infections [46, 49, 50]. 
Definitive diagnosis of filariasis requires blood smear examination 
for microfilariae or the presence of circulating filarial antigen. Se-
rological testing may be helpful in appropriate clinical settings. Un-
less they use the single recombinant antigen Wb 123 (which is not 
commercially available) [51], antifilarial serologic antibody tests 
do not differentiate between the various types of filarial infections 
and often show a cross-reaction with antigens from other diseases 
caused by helminths [52]. They do not allow differentiation be-
tween acute and chronic infection [53]. Species-specific polymer-
ase chain reaction techniques have been used but they are not com-
mercially available [54, 55]. Examination of concentrated [56] 
blood smears using Giemsa or Wright stains (taken during the noc-
turnal activity period) for microfilariae is a second-line diagnostic 
tool if circulating antigen testing is not available or Brugian filaria-
sis is suspected [57, 58]. Morphologic characteristics on blood 
smear allow differentiation of the LF species. W. bancrofti and both 
Brugia species have an acellular staining sheath visible on light mi-
croscopy. W. bancrofti has no nuclei in its tail whereas B. malayi has 
terminal and subterminal nuclei in its tail.
Imaging diagnosis
Imaging in general and ultrasound specifically may demonstrate 
the parasites’ respective complications [59–63]. Damaging con-
ventional X-ray contrast lymphangiography has been replaced by 
scintigraphy [33].
X-ray lymphangiograms made in patients with filarial lymphede-
ma show a typical pattern of varicosities which clearly differentiate 
this condition from lymphostatic verrucosis, the prevalent form of 
non-filarial lymphedema [64]. Also, lymphography was useful in 
the treatment of chyluria [65]. Contrast lymphangiography, while 
widely used to visualize the morphology of the lymphatic vessels 
[66], carries the potential risk of lymphatic damage. The unpredict-
able consequences of such studies have hampered the early eval-
uation of the lymphatics of asymptomatic individuals [67]. To over-
come these difficulties, lymphoscintigraphy using radiolabeled al-
bumin or dextran has been developed [68]. This technique can be 
performed and repeated safely so that serial studies of individuals 
a
b
▶Fig. 4 Lymph scrotum with thickened skin a. Thickness can be 
measured by ultrasound b.
a
b
▶Fig. 5 Breast filariasis. B-mode imaging a and color Doppler 
imaging of breast filariasis b. Irregular amplitudes of color signals 
could be used to make a differential diagnosis.
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are possible. Preliminary studies with this technique have demon-
strated the presence of lymphatic abnormalities in asymptomatic 
microfilaremics with no evidence of edema. Lymphoscintigraphy 
allows clear and precise analysis of lymphatic system function in 
patients at risk. This technique could be used for the examination 
of infected but asymptomatic individuals to determine whether 
they have morphological or functional lymphatic abnormalities and 
how these alterations could be changed, especially by chemother-
apy. It could also provide a new epidemiological tool for detailed 
studies of morbidity due to endemic filariasis.
Ultrasound allows the detection of moving adult worms in lym-
phatic vessels (“filarial dance sign”) and also monitoring of the ef-
fectiveness of treatment [69–77] (▶Video 1). Pulsating blood ves-
sels can be differentiated from irregular moving worms containing 
lymphatics by Doppler ultrasound [78–81] (▶Video 2). The “filar-
ial dance sign” has been observed in many organs including the 
limbs [71, 80] ▶Fig. 1, scrotum [69, 70, 72–74, 82–84] ▶Fig. 2 and 
▶Fig. 3, breast and axillary lymphatics [75, 78, 85, 86] ▶Fig. 4 and 
▶Fig. 5 or cord ▶Fig. 6. The role of different ultrasound techniques 
in evaluating lymphatic disease has been extensively described 
[87–95]. The role of contrast-enhanced ultrasound [88, 96–102] 
and elastography [99–101, 103–106] in the evaluation of filariasis 
has not yet been described. Both methods might be helpful in iden-
tifying fibrosis and scars. Contrast-enhanced ultrasound can also 
be used to evaluate the lymphatic tissue directly [107, 108].
Almost no helpful and specific experience has been published 
about CT [109–111] and MRI [112–115] findings in filariasis also 
due to the small size of the parasites.
Differential Diagnosis
The differential diagnosis of LF with retrograde lymphedema in-
cludes primary lymphedema, progressive cellulitis, neoplastic dis-
eases (e. g., cancer) and a variety of inflammatory diseases (e. g., 
antegrade bacterial lymphangitis, tuberculosis), as well as loiasis, 
onchocerciasis, podoconiosis (abnormal inflammatory reaction to 
mineral particles in altitudes higher than mosquito transmission 
zones for filariasis (above 1 500 m)) [116]. Loiasis and onchocerci-
asis are rarely associated with lymphedema.
The filarial nematode L. loa causes loiasis. The diagnosis is estab-
lished by identifying the migrating adult worm in the subcutaneous 
tissue swelling (calabar) of the distal limbs and during the subcon-
junctival migration of the worm around the orbita or by detecting 
microfilariae in a blood smear [47, 117, 118]. False-positive antigen 
tests for W. bancrofti in the setting of L. loa microfilaremia may com-
plicate the diagnosis of occult W. bancrofti in coinfected patients.
The filarial nematode Onchocerca volvulus causes onchocercia-
sis. The clinical manifestations include skin and eye involvement 
and systemic manifestations. The so-called “hanging groin” is a re-
sult of skin atrophy of the groin and anterior thigh. Chains of (scary) 
lymph nodes result in folds of loose skin.
Treatment
Early treatment is recommended also in asymptomatic patients to 
prevent lymphatic disease. In patients with advanced disease with 
scars and fibrotic tissue, treatment success is less obvious. The 
treatment of local and systemic secondary bacterial infections is 
mandatory and includes regular antibiotics and prophylactic anti-
biotics in some cases and the use of antibacterial creams on dam-
aged skin and small erosions. Careful attention to hygiene includ-
ing regular nail cleaning, wearing of shoes, washing of affected 
areas daily, etc. is important. The affected limb(s) should be regu-
larly exercised and if necessary lymph flow should be enhanced by 
complex decongestive therapy (CDT). Elevation of the affected limb 
during the night is recommended after the exclusion of arterial 
 occlusive disease.
The standard treatment of choice in monoinfection of Wucheria 
bancrofti, Brugia malayi, and Brugia timori is diethylcarbamazine 
(DEC, 6–10 mg/kg for up to 2 (3) weeks) [1, 119–121]. The dosage 
and mechanism of action depend on the species [122–124]. DEC 
is not recommended in pregnancy.
Patients with proven or suspected coinfection of LF and oncho-
cerciasis without ocular involvement should undergo treatment of 
onchocerciasis first. LF pre-treatment in the form of ivermectin 
150 μg/kg in a single dose should be given to reduce the microfi-
larial load [124–129]. Ivermectin can be followed by the above-
a
b
▶Fig. 6 Cord filariasis, grayscale imaging of cord filariasis a, de-
tailed view of small adult worms b.
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mentioned standard treatment for LF, DEC after one month or later 
[130, 131]. Doxycycline (200 mg orally once daily for four to six weeks) 
followed by ivermectin (150 μg/kg orally single dose) can be used 
as an alternative to the standard treatment [132]. It is macrofilari-
cidal, i. e. it kills the adult worms and constitutes a curative thera-
py.
Albendazole shows at least partial macrofilaricidal activity 
against adult worms and has been effective and safe in patients 
with concomitant loiasis or onchocerciasis [133, 134]. Complex 
lymphatic decongestive physiotherapy should accompany drug 
treatment.
Surgical drainage of hydroceles may give immediate relief but 
recurrence may occur [19].
The reproductive lifespan of adult parasites has been estimated 
to be 4–6 years, explaining the effectiveness of mass treatment pro-
grams (Global Program for the Elimination of LF) [121, 135–138]. 
Such programs have suppressed transmission to < 1 percent. W. ban-
crofti has no animal hosts and might be the best target for elimina-
tion. Other filariases, e. g., Brugian, have a domestic and wild animal 
reservoir and elimination does not seem feasible. Triple-drug single 
dose treatment with ivermectin, diethylcarbamazine, and albenda-
zole has been successful in endemic areas [139, 140].
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